Skip to main content

Table 4 KEGG analysis of leukemia related pathways

From: Identification of potential pathways and microRNA-mRNA networks associated with benzene metabolite hydroquinone-induced hematotoxicity in human leukemia K562 cells

KEGG term

ID

Input number

Background number

Regulated

Genes

Chronic myeloid leukemia

hsa05220

4

73

up

CRK, CHUK, NFKB1, NRAS

6

73

down

STAT5B, MAP 2 K2, PIK3CD, GAB2, SHC2, MAPK3

Acute myeloid leukemia

hsa05221

4

57

up

KIT, CHUK, NFKB1, NRAS

8

57

down

PPARD, MAP2K2, SPI1, PIM1, PIK3CD, STAT5B, MAPK3, STAT3

Hematopoietic cell lineage

hsa04640

4

88

up

KIT, CD44, THPO, ITGA3

9

88

down

ITGAM, ITGA2B, CD19, ANPEP, CD33, CD7, IL9R, CD37, ITGA5

Human T-cell leukemia virus 1 infection

hsa05166

17

261

up

PCNA, ANAPC10, CDC23, NFKB1, POLE3, FOSL1, ATR, VAC14, CDC26, CHUK, ETS2, POLE4, RANBP1, VDAC3, MRAS, CREM, NRAS

22

261

down

STAT5B, HLA-E, TP53INP1, HLA-A, NFATC2, TNFRSF13C, FZD4, FZD2, IL15RA, PIK3CD, TLN1, NFATC4, HLA-B, WNT11, ATF3, SPI1, RRAS, MAP3K3, WNT6, HLA-C, TSPO, SLC25A6